In CAC patients with small tumor size (<4 cm), PAX1m-positive patients showed a longer 5-year PFS, suggesting that PAX1 gene methylation might be useful for monitoring the 5-year progression in CAC patients with small tumor size. The gene discussed is PAX1; the disease is neoplasm.